Your browser doesn't support javascript.
loading
A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022.
Gupta, Ravi Kumar; Gupta, Ashish; Hillengass, Jens; Holstein, Sarah A; Suman, Vera J; Taneja, Alankrita; McCarthy, Philip L.
Affiliation
  • Gupta RK; Department of Internal Medicine, Larkin Community Hospital, South Miami, Florida, USA.
  • Gupta A; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Hillengass J; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Holstein SA; Department of Internal Medicine, Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA.
  • Suman VJ; Department of Health Sciences, Division of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Taneja A; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • McCarthy PL; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Expert Rev Anticancer Ther ; 22(5): 457-469, 2022 05.
Article in En | MEDLINE | ID: mdl-35503516
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Multiple Myeloma Limits: Humans Language: En Journal: Expert Rev Anticancer Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Multiple Myeloma Limits: Humans Language: En Journal: Expert Rev Anticancer Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: